| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |